A retrospective study reported high recent use of GLP-1 receptor agonists in people living with HIV at a UK centre, with ...

CROWN is the first large, phase IIIb trial to evaluate the investigational use of LA Cabenuva versus daily oral therapy in ...

As the population of people with HIV ages, researchers studied cognitive health changes; 46% of study participants were ...

University of British Columbia news release. The HPV vaccine provides strong, long-lasting protection for women living with ...

Women with HIV have almost twice the risk of CVD compared to women without HIV, while men with HIV have a 44% increased risk ...

ECDC released a report assessing the current situation regarding availability and access to prevention, testing, and ...

Mirum Pharmaceuticals press release. Mirum Pharmaceuticals, Inc. announced the primary endpoint was met in the Phase 3 ...

Among women with steatotic liver disease, HIV was associated with 48% greater adjusted odds of clinically significant ...

Researchers and clinicians are turning to new tools amidst an evolution in strategies for reducing cardiovascular risk in ...

HIV-positive people had elevated rates of both infection-related malignancies and cancers not linked to infections.

WHO announced a major expansion of its prequalification programme to include a wider range of life-saving medical devices ...

Study offered a potential explanation for why neurological complications persist despite antiretroviral treatment.